ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (ONLINE)
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
No Association between the Plasmodium vivax MS334 or In9 Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal Expansion.
june23:0161022.
2023-01-01
-
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc.
1:1-15.
2023-01-01
-
Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors.
67:1-16.
2023-01-01
-
Population Pharmacokinetic Modeling of Free Plasma and Free Brain Concentrations of Ceftaroline in Healthy and Methicillin-Resistant Staphylococcus aureus-Infected Wistar Rats.
67:1-12.
2023-01-01
-
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
01:1-9.
2022-01-01
-
Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model.
66:1-7.
2022-01-01
-
Aspergillus fumigatus FhdA Transcription Factor Is Important for Mitochondrial Activity and Codon Usage Regulation during the Caspofungin Paradoxical Effect.
1:1-10.
2022-01-01
-
Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.
66:10.1128/aac.023.
2022-01-01
-
Characterization of a Carbapenem-Resistant BKC-1-Producing Clinical Isolate Belonging to the Pseudomonas putida Group from Brazil.
66:1-22.
2022-01-01
-
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo.
66:1-10.
2022-01-01
-
ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles.
14:1-6.
2022-01-01
-
Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.
xx:xxx-xxx.
2022-01-01
-
Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
1:1.
2022-01-01
-
New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in : Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death.
66:e00767-21.
2022-01-01
-
Population Pharmacokinetic Modeling and Probability of Target Attainment of Ceftaroline in Brain and Soft Tissues.
66:1-12.
2022-01-01
-
Role of IS Kpn23 in bla BKC-1 Expression and Mobilization.
66:1-5.
2022-01-01
-
Validation of Clinical Risk Models for Clostridioides difficile Attributable Outcomes.
1:1-12.
2022-01-01
-
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.
66:e0175121.
2022-01-01
-
tRNA-Met Inactivating Mycobacterium tuberculosis VapBC Toxin-Antitoxin Systems as Therapeutic Targets.
67:e0189621.
2022-01-01
-
Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.
65:e02141-20.
2021-01-01
-
Anti-virulence Bispecific Monoclonal Antibody Mediated Protection Against Ventilator-Associated Pneumonia in a Rabbit Model.
AAC.02:1-25.
2021-01-01
-
Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex.
65:e0005621.
2021-01-01
-
Antifungal activity of Acylhydrazone derivatives against Sporothrix spp..
1:00.
2021-01-01
-
Antifungal activity of Acylhydrazone derivatives against spp..
Online:02593-20.
2021-01-01
-
BKC-2, a New BKC Variant Detected in MCR-9.1-Producing Enterobacter hormaechei subsp..
65:e01193.
2021-01-01
-
Effect of Itraconazole-Ezetimibe-Miltefosine Ternary Therapy in Murine Visceral Leishmaniasis.
000:000.
2021-01-01
-
Effect of melanin biosynthesis inhibition in the antifungal susceptibility of chromoblastomycosis agents.
1:1-9.
2021-01-01
-
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.
65:e01204-21.
2021-01-01
-
Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing in kidney transplant recipients: a propensity score and DOOR-based analysis..
2:1102.
2021-01-01
-
Exploring Ubiquinone Biosynthesis Inhibition as a Strategy for Improving Atovaquone Efficacy in Malaria.
65:1516-20.
2021-01-01
-
In Vitro and In Vivo Antifungal Activity of Buparvaquone against Sporothrix brasiliensis.
1:1-21.
2021-01-01
-
Monoclonal antibodies against cell wall chitooligomers as accessory tools for the control of cryptococcosis.
65:1-14.
2021-01-01
-
NIKKOMYCIN Z AGAINST DISSEMINATED COCCIDIOIDOMYCOSIS IN A MURINE MODEL OF SUSTAINED RELEASE DOSING.
-:-.
2021-01-01
-
New insights into the mechanism of action of the cyclopalladated complex - CP2 in Leishmania : Calcium Dysregulation, Mitochondrial Dysfunction and Cell Death.
66:1.
2021-01-01
-
Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.
1:00-12.
2021-01-01
-
Pharmacokinetics of Polymyxin B in Hospitalized Adults with Cystic Fibrosis.
65:e0079221.
2021-01-01
-
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Kidney Transplant Recipients.
65:e0110221-xx.
2021-01-01
-
Small IncQ1 Plasmid Encoding KPC-2 Expands to Invasive Non-Typhoidal Salmonella.
65:1-3.
2021-01-01
-
The antimicrobial peptide MK58911-NH2 acts on planktonic, biofilm and intramacrophage cells of.
1:1.
2021-01-01
-
The antimicrobial peptide MK58911-NH2 acts on planktonic, biofilm and intramacrophage cells of Cryptococcus neoformans.
1:AAC0090421.
2021-01-01
-
A Tetrahydrophthalazinone Inhibitor of Phosphodiesterase with In Vitro Activity Against Intracellular Trypanosomatids.
20:1-5.
2020-01-01
-
A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to (IRONIC study).
02494:02494-19.
2020-01-01
-
A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa (IRONIC study).
xx:e02494-19-e02494-19.
2020-01-01
-
Accumulation of Major Linezolid Metabolites in Patients with Renal Impairment.
64:1.
2020-01-01
-
Amlodipine increases the therapeutic potential of ravuconazole upon T rypanosoma cruzi infection.
.:.-e02519.
2020-01-01
-
Amlodipine increases the therapeutic potential of ravuconazole upon T infection.
64:32423960.
2020-01-01
-
Amlodipine increases the therapeutic potential of ravuconazole upon Trypanosoma cruzi infection.
64:1-14.
2020-01-01
-
Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production.
-:--12.
2020-01-01
-
BKC-2, a New BKC Variant Detected in MCR-9.1-producing Enterobacter hormaechei subsp. xiangfangensis.
65:AAC.01193-20.
2020-01-01
-
Chitosan Ameliorates Virulence in a Infection Model.
64:e00476.
2020-01-01
-
Combination therapy using benznidazole and aspirin during the acute phase of experimental Chagas disease prevents cardiovascular dysfunction and decreases typical cardiac lesions in the chronic phase..
1:1-11.
2020-01-01
-
Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax.
1:1-10.
2020-01-01
-
Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for and.
64:e02041-19.
2020-01-01
-
Correction for Ferreira et al., -Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax -.
64:01.
2020-01-01
-
Correction for Ferreira et al., -Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for and -.
64:1-5.
2020-01-01
-
Correlation of Trichosporon asahii genotypes with anatomical sites and antifungal susceptibility profiles: data analyses from 284 isolates collected in the last 22 years across 24 medical centers.
01:1.
2020-01-01
-
Development of probiotic formulations for oral candidiasis prevention: Gellan gum as a carrier to deliver Lactobacillus paracasei 28.4.
1:1-1.
2020-01-01
-
Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of.
64:e00414-20-e00414-20.
2020-01-01
-
Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
64:00-10.
2020-01-01
-
Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro.
1:1.
2020-01-01
-
Emergence of Mycobacterium leprae rifampicin resistance evaluated by whole-genome sequencing after 48 years of irregular treatment.
-:--04.
2020-01-01
-
Emergence of rifampicin resistance evaluated by whole-genome sequencing after 48 years of irregular treatment.
April:x.
2020-01-01
-
Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.
64:001148.
2020-01-01
-
Fenbendazole Controls In Vitro Growth, Virulence Potential, and Animal Infection in the Cryptococcus Model.
-:--1.
2020-01-01
-
Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.
64:1.
2020-01-01
-
Gallic and Ellagic Acids Are Promising Adjuvants to Conventional Amphotericin B for the Treatment of Cutaneous Leishmaniasis.
64:01-14.
2020-01-01
-
Identification of off-patent drugs that show synergism with Amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp..
64:1-16.
2020-01-01
-
Identification of off-patent drugs that show synergism with Amphotericin B or that present antifungal action against and spp..
-:1.
2020-01-01
-
In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis.
64:17.
2020-01-01
-
In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis.
64:e01188-20-e01188-20.
2020-01-01
-
Influence of CYP2C8 , CYP3A4 , and CYP3A5 Host Genotypes on Early Recurrence of Plasmodium vivax.
1:1-5.
2020-01-01
-
Lychnopholide in Poly(D,L-Lactide)- Block -Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases.
1:1-30.
2020-01-01
-
Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence.
000:000-14.
2020-01-01
-
Novel insights into therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence.
64:e02056-19.
2020-01-01
-
Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the mouse-Berenice-78 Strain Model.
65:01383-20.
2020-01-01
-
Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
1:1-7.
2020-01-01
-
Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
64:1-11.
2020-01-01
-
Synthesis and Biological Activity of Novel Zinc-Itraconazole Complexes in Protozoan Parasites and Sporothrix spp..
64:1.
2020-01-01
-
Synthesis and biological activity of novel zinc-itraconazole complexes in protozoan parasites and Sporothrix spp..
64:1-140.
2020-01-01
-
Therapeutic effect of diminazene aceturate on parasitic blood fluke Schistosoma mansoni infection.
-:1-13.
2020-01-01
-
Therapeutic effect of diminazene aceturate on parasitic blood fluke Schistosoma mansoni infection.
64:1-26.
2020-01-01
-
Therapeutic efficacy of a mixed formulation of conventional and PEGylated liposomes containing meglumine antimoniate, combined with allopurinol, in dogs naturally infected with.
x:x-x.
2020-01-01
-
Therapeutic efficacy of a mixed formulation of conventional and PEGylated liposomes containing meglumine antimoniate, combined with allopurinol, in dogs naturally infected with Leishmania infantum.
64:1-13.
2020-01-01
-
Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
64:00142-20-1.
2020-01-01
tem uma área de assunto
publisher
-
American Society for Microbiology
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S47215897
International Standard Serial Number (ISSN)
-
0066-4804
-
1070-6283
-
1098-6596